A powerful personal journey to mark Macula Month
Read MoreA powerful personal journey to mark Macula Month
Read MoreMacular Disease Foundation Australia (MDFA) is pleased with the Federal Government’s increased investment to make primary health care more affordable and accessible for Australians doing it tough due to the current cost of living crisis.
Read MoreMacular Disease Foundation Australia (MDFA) has welcomed the Federal Government’s decision to defer the private health insurance reclassification of intravitreal (eye) injections from 1 July 2025 to 1 July 2026 and undertake further consultation.
Read MoreWe have released new research in collaboration with the University of New South Wales which has revealed the median total cost for people living with macular disease, who also receive sight-saving eye injections, is 12 percent* ($3,621) of the annual government pension payment.
Read MoreBy The Hon. Jillian Skinner, AM, former NSW Minister for Health.This article was originally published by News Corp.
Read MoreMacular Disease Foundation Australia calls on the next Federal Government to bulk-bill sight-saving eye injections for pensioners; with the potential for creating a $140 million cost-saving per year.
Read MoreMacular Disease Foundation Australia (MDFA) has announced the launch of its inaugural MDFA 25th Anniversary Award
Read MoreThe Therapeutic Goods Administration (TGA) approval of the new eye injection treatment SYFOVRE® (pegcetacoplan) is welcome news, as it will give many people with Geographic Atrophy a treatment option that they’ve never had before to slow the progression of the disease.
Read More